Research Article
Metadichol®: A Novel Nanolipid Formulation That Inhibits SARS-CoV-2 and a Multitude of Pathological Viruses In Vitro
| Sample | Concentration | RFU | % inhibition | IC50 |
| Control | 0 | 43233358 | 0.00 | |
| Metadichol (ng/mL) | 1.56 | 41305150 | 4.46 | 96.65 ng/mL | 3.12 | 39329385 | 9.03 | | 6.25 | 36713767 | 15.08 | | 12.5 | 33778222 | 21.87 | | 25 | 30695684 | 29.00 | | 50 | 26087008 | 39.66 | | 100 | 16009312 | 62.97 | |
| Camostat mesylate (μg/mL) | 0.78 | 37984828 | 12.14 | 26.46 μg/mL | 1.56 | 35235186 | 18.50 | | 3.125 | 31685728 | 26.71 | | 6.25 | 29234396 | 32.38 | | 12.5 | 23276839 | 46.16 | | 25 | 18931887 | 56.21 | | 50 | 8797988 | 79.65 | |
|
|